Kyowa Kirin Invests $530 Million in U.S. Biologics Manufacturing Facility

URLhttps://patrickwareing.com/news/kyowa-kirin-invest
Sourcepatrickwareing.com
Date Published04/12/2025

Additional Reshoring Information:

Company/Division name Kyowa Kirin
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):100
Year reshoring announced:2025
Year reshoring implemented or to be implemented:2027
Domestically, the work will be done:In-house
Capital investment ($):530
Country(ies) from which reshored:Japan
City reshored to:Sanford
State(s) reshored to:NC
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredbiologics, pharmaceuticals
What non-domestic negative factors made offshoring less attractive?Supply chain interruption
What domestic positive factors made reshoring more attractive?Government Incentives, Lead time/Time to market
Government Incentive dollar amount:$10 million
Find Reshoring Articles